CanSino Biologics Statistics
Total Valuation
CASBF has a market cap or net worth of 1.64 billion. The enterprise value is 1.45 billion.
| Market Cap | 1.64B |
| Enterprise Value | 1.45B |
Important Dates
The next estimated earnings date is Thursday, March 5, 2026.
| Earnings Date | Mar 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 132.67M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.66% |
| Shares Change (QoQ) | -40.81% |
| Owned by Insiders (%) | 31.39% |
| Owned by Institutions (%) | 6.95% |
| Float | 159.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 49.82 |
| PS Ratio | 12.03 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 76.11 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -72.74 |
| EV / Sales | 10.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -65.98 |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.29.
| Current Ratio | 3.62 |
| Quick Ratio | 3.24 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | -9.10 |
| Interest Coverage | -4.67 |
Financial Efficiency
Return on equity (ROE) is -2.84% and return on invested capital (ROIC) is -6.46%.
| Return on Equity (ROE) | -2.84% |
| Return on Assets (ROA) | -1.87% |
| Return on Invested Capital (ROIC) | -6.46% |
| Return on Capital Employed (ROCE) | -3.68% |
| Weighted Average Cost of Capital (WACC) | 10.54% |
| Revenue Per Employee | 123,537 |
| Profits Per Employee | -18,055 |
| Employee Count | 1,115 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.71 |
Taxes
| Income Tax | -699,226 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.60% in the last 52 weeks. The beta is 1.31, so CASBF's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | +32.60% |
| 50-Day Moving Average | 4.22 |
| 200-Day Moving Average | 5.84 |
| Relative Strength Index (RSI) | 46.12 |
| Average Volume (20 Days) | 3,208 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CASBF had revenue of 136.51 million and -19.95 million in losses. Loss per share was -0.08.
| Revenue | 136.51M |
| Gross Profit | 101.35M |
| Operating Income | -32.12M |
| Pretax Income | -20.65M |
| Net Income | -19.95M |
| EBITDA | -11.86M |
| EBIT | -32.12M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 392.06 million in cash and 200.22 million in debt, with a net cash position of 191.84 million.
| Cash & Cash Equivalents | 392.06M |
| Total Debt | 200.22M |
| Net Cash | 191.84M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 692.68M |
| Book Value Per Share | 3.79 |
| Working Capital | 400.52M |
Cash Flow
In the last 12 months, operating cash flow was 21.58 million and capital expenditures -43.58 million, giving a free cash flow of -22.00 million.
| Operating Cash Flow | 21.58M |
| Capital Expenditures | -43.58M |
| Free Cash Flow | -22.00M |
| FCF Per Share | n/a |
Margins
Gross margin is 74.24%, with operating and profit margins of -23.53% and -14.62%.
| Gross Margin | 74.24% |
| Operating Margin | -23.53% |
| Pretax Margin | -15.13% |
| Profit Margin | -14.62% |
| EBITDA Margin | -8.69% |
| EBIT Margin | -23.53% |
| FCF Margin | n/a |
Dividends & Yields
CASBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.66% |
| Shareholder Yield | 1.66% |
| Earnings Yield | -1.21% |
| FCF Yield | -1.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CASBF has an Altman Z-Score of 3.12 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.12 |
| Piotroski F-Score | 5 |